Are antithyroid drugs immunosuppressive?
- 18 February 1984
- Vol. 288 (6416) , 509-511
- https://doi.org/10.1136/bmj.288.6416.509
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- OUTCOME OF PATIENTS WITH GRAVES' DISEASE AFTER LONG‐TERM MEDICAL TREATMENT GUIDED BY TRIIODOTHYRONINE (T3) SUPPRESSION TESTClinical Endocrinology, 1983
- Methimazole inhibits thyroid autoantibody production by an action on accessory cellsClinical Immunology and Immunopathology, 1983
- Carbimazole and the Autoimmune Response in Graves' DiseaseNew England Journal of Medicine, 1980
- MODE OF ACTION OF CARBIMAZOLE IN GRAVES' DISEASEClinical Endocrinology, 1979
- Short-Term Antithyroid Drug Therapy for the Thyrotoxicosis of Graves's DiseaseNew England Journal of Medicine, 1977
- Single-dose, "Block-Replace" Drug Therapy in HyperthyroidismBMJ, 1973
- Remission of Thyrotoxicosis during Treatment with PropranololBMJ, 1973
- SEQUENTIAL ASSESSMENT DURING DRUG TREATMENT OF THYROTOXICOSISClinical Endocrinology, 1973
- STUDIES OF THYROID FUNCTION USING99TcmIN THYROTOXIC PATIENTS DURING TREATMENT WITH ANTITHYROID DRUGSClinical Endocrinology, 1973
- Thyroid Suppressibility: Follow-up for Two Years after Antithyroid TreatmentBMJ, 1971